Lei Chengqiang, Liu Jian, Liu Xiangyong, Yang Zhi
Cardiology. 2025 Jun 19:1-20. doi: 10.1159/000546878.
Rheumatic heart disease (RHD) is a globally important public health issue. China, as a populous country, has daunting challenges posed by RHD-related morbidity and mortality in the public health system. Evaluating and comparing the differences in the RHD burden of children and adolescents versus adults in China not only helps optimize domestic prevention and control strategies but also provides a reference for regional practices in RHD control.
This study aimed to illuminate the temporal trends in the age and gender burden of RHD in Chinese children and adolescents from 1990 to 2021, and to compare it with the burden of the disease in adults.
Open data from the 2021 Global Burden of Disease database were utilized to analyze the characteristics of the RHD burden of children, adolescents, and adults in China, including changes in morbidity and mortality. Joinpoint was utilized to calculate the average annual percentage change (AAPC). A comprehensive comparative analysis was undertaken on the differences in RHD burden in Chinese children, adolescents, and adults from multiple dimensions such as age, gender, and time.
From 1990 to 2021, the number of deaths of RHD in children and adolescents in China exhibited a declining trend compared to that in adults. In terms of the number of incidences, all age groups showed a declining trend except for those aged 55 and above, which manifested an upward trend. The crude incidence and crude mortality rates both declined during the same period, with their AAPC being -0.53 (95% CI: -0.61, -0.46) and -8.13 (95% CI: -8.65, -7.61) for those aged under 20 years, and -1.92 (95% CI: -2.05, -1.80) and -2.98 (95% CI: -3.18, -2.79) for those aged 20 years and above. The incidence and mortality rates had a bearing on patient age, with higher incidence rates observed in children and adolescents and higher mortality rates observed in adults. According to the analysis of gender differences, the incidence of children and adolescents was higher in men, while women had always higher crude incidence rate (CIR) and mortality rate (CDR) than men (CIR in 2021: 21.31/100000 for women vs. 20.08/100000 for men; CDR: 0.05/100000 for women vs. 0.06/100000 for men). The mortality rate of adult women was particularly prominent. The number of cases in children and adolescents exhibited a "W-shaped" fluctuation, while the adult group showed an "M-shaped" trend.
风湿性心脏病(RHD)是一个全球重要的公共卫生问题。中国作为一个人口大国,公共卫生系统面临着与RHD相关的发病率和死亡率带来的严峻挑战。评估和比较中国儿童和青少年与成年人的RHD负担差异,不仅有助于优化国内防控策略,也为RHD防控的区域实践提供参考。
本研究旨在阐明1990年至2021年中国儿童和青少年RHD年龄和性别负担的时间趋势,并与成年人的疾病负担进行比较。
利用2021年全球疾病负担数据库的公开数据,分析中国儿童、青少年和成年人RHD负担的特征,包括发病率和死亡率的变化。采用Joinpoint计算平均年度百分比变化(AAPC)。从年龄、性别和时间等多个维度,对中国儿童、青少年和成年人RHD负担的差异进行综合比较分析。
1990年至2021年,中国儿童和青少年RHD死亡人数与成年人相比呈下降趋势。在发病率方面,除55岁及以上年龄组呈上升趋势外,所有年龄组均呈下降趋势。同期粗发病率和粗死亡率均下降,20岁以下人群的AAPC分别为-0.53(95%CI:-0.61,-0.46)和-8.13(95%CI:-8.65,-7.61),20岁及以上人群的AAPC分别为-1.92(95%CI:-2.05,-1.80)和-2.98(95%CI:-3.18,-2.79)。发病率和死亡率与患者年龄有关,儿童和青少年发病率较高,成年人死亡率较高。根据性别差异分析,儿童和青少年男性发病率较高,而女性的粗发病率(CIR)和死亡率(CDR)始终高于男性(2021年CIR:女性为21.31/10万,男性为20.08/10万;CDR:女性为0.05/10万,男性为0.06/10万)。成年女性的死亡率尤为突出。儿童和青少年病例数呈“W形”波动,而成人组呈“M形”趋势。